Publication | Closed Access

The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction

InflammationHeart FailureFibrosisCardiac ReprogrammingCardiovascular DiseaseImmunologyMyocardial FibrosisPathologyAcute Myocardial InfarctionMedicineCell BiologyCardiologyMouse ModelCardiac PathologyMyocardial Infarction